SynthesisJMIR mental health2026
The Performance of Wearable Device-Based Artificial Intelligence in Detecting Depression: Systematic Review and Meta-Analysis.
Synthesis in JMIR mental health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: In recent years, advances in wearable sensor technology and artificial intelligence (AI) have provided new possibilities for detecting and monitoring depression. Objective: This study systematically reviewed and meta-analyzed the diagnostic and predictive performance of wearable device-based AI models for detecting depression and predicting depressive episodes and explored factors influencing outcomes. Methods: Following PRISMA-DTA (Preferred Reporting Items for a Systematic Review and Meta-Analysis of Diagnostic Test Accuracy) guidelines, the PubMed, Embase, Web of Science, and PsycINFO databases were searched from inception to May 27, 2025. Eligible studies used AI algorithms on wearable device data for depression detection or episode prediction. Sensitivity, specificity, diagnostic odds ratio, and area under the curve (AUC) were pooled using a bivariate random effects model. Risk of bias was assessed using Prediction Model Risk of Bias Assessment Tool plus artificial intelligence (PROBAST+ AI), and certainty of evidence was assessed using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) tool. Results: We included 16 studies (32 datasets) with 1189 patients and 13,593 samples. For depression detection, pooled sensitivity and specificity were 0.89 (95% CI 0.83-0.93) and 0.93 (95% CI 0.87-0.96), with a diagnostic odds ratio of 110.47 (95% CI 33.33-366.17) and AUC of 0.96 (95% CI 0.94-0.98). Random forest models showed the best performance (sensitivity=0.89, specificity=0.91, AUC=0.97). Subgroup analyses indicated that study design, AI method, reference standard, and input type significantly affected diagnostic accuracy (P<.05). For depressive episode prediction (3 datasets), pooled sensitivity was 0.86 (95% CI 0.80-0.91), and pooled specificity was 0.65 (95% CI 0.59-0.71). The overall risk of bias was low to moderate, with no evidence of publication bias. Conclusions: Wearable device-based AI models achieved high accuracy for detecting depression and moderate utility in predicting episodes. However, heterogeneity, reliance on retrospective and public datasets, and lack of standardized methods limited generalizability.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.